InvestorsObserver
×
News Home

Is Agile Therapeutics Inc (AGRX) Stock Worth a Buy Monday?

Monday, December 07, 2020 10:44 AM | InvestorsObserver Analysts

Mentioned in this article

Is Agile Therapeutics Inc (AGRX) Stock Worth a Buy Monday?

Agile Therapeutics Inc (AGRX) stock has gained 50.75% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives AGRX stock a score of 67 out of a possible 100.

That rank is primarily influenced by a fundamental score of 97. In addition to the average rating from Wall Street analysts, AGRX stock has a mean target price of 8.5. This means analysts expect the stock to add 183.33% over the next 12 months. AGRX's rank also includes a short-term technical score of 61. The long-term technical score for AGRX is 44.

Overall Score - 67
AGRX has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on AGRX!

What's Happening with AGRX Stock Today

Agile Therapeutics Inc (AGRX) stock is flat 0% while the S&P 500 is down -0.1% as of 10:42 AM on Monday, Dec 7. AGRX is flat $0.00 from the previous closing price of $3.00 on volume of 1,040,634 shares. Over the past year the S&P 500 is up 17.84% while AGRX has gained 50.75%. AGRX lost -$0.50 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Agile Therapeutics Inc (AGRX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App